...
首页> 外文期刊>The American journal on addictions / >Physician and Pharmacist: Attitudes, Facilitators, and Barriers to Prescribing Naloxone for Home Rescue
【24h】

Physician and Pharmacist: Attitudes, Facilitators, and Barriers to Prescribing Naloxone for Home Rescue

机译:医生和药剂师:为家庭救援处方纳尔诺酮的态度,促进者和障碍

获取原文
获取原文并翻译 | 示例

摘要

Background and Objectives We implemented a naloxone education and distribution program in our academic health system. Despite the program, naloxone prescribing was not fully realized. This study aimed to identify the barriers to prescribing. Methods We conducted a prospective, cross‐sectional, mixed‐methods study of naloxone prescribers. Participants completed a questionnaire regarding their prescribing practices, attitudes, facilitators, and barriers to prescribing naloxone. Participants were then invited for an interview to further explore these topics and elicit more in‐depth explanations. Results Sixty‐four physicians and eight pharmacists completed the questionnaire ( n ?=?72). The most commonly reported barrier to prescribing naloxone was time constraints (33%). During the interviews, 14 subthemes emerged within four themes: provider competency, provider beliefs, health care system, and patient factors/social climate. Discussion Prescribers identified barriers to naloxone prescribing despite implementation of an institutional overdose education and naloxone distribution (OEND) program. The results were similar to those previously reported prior to initiation of such programs. Conclusion In this study, we examined barriers and facilitators to naloxone prescribing. Although previous studies have shown that health care providers endorsed similar barriers, our study indicates that some of those barriers persist despite a concerted effort to educate and promote prescribing via an OEND. While our study is limited by a small, selective sample size the results indicate that improvements to our OEND program are warranted. Scientific Significance Our study addressed an unexplored area of OEND research and may inform future program development. (Am J Addict 2019;00:00–00)
机译:背景和目标我们在学术卫生系统中实施了纳洛酮教育和分销计划。尽管该计划,但纳诺酮处方没有完全实现。本研究旨在识别规定的障碍。方法我们进行了纳洛酮处方的前瞻性,横截面,混合方法研究。与会者在规定纳洛酮的规定实践,态度,促进者和障碍方面完成了调查问卷。然后邀请参与者接受采访进一步探索这些主题并引出更深入的解释。结果六十四名医生和八名药剂师完成了调查问卷(N?=?72)。最常用的纳洛酮报告的障碍是时间约束(33%)。在访谈期间,在四个主题中出现了14个子上议:提供商能力,提供者信仰,医疗保健系统和患者因素/社会气候。尽管实施了机构过量教育和纳洛酮分布(oend)计划,但讨论规定仍然确定了纳洛酮规定的障碍。结果与先前在启动此类方案之前报告的结果类似。结论在这项研究中,我们将障碍和促进者审查给纳洛酮处方。虽然以前的研究表明,医疗保健提供者赞同类似的障碍,但我们的研究表明,尽管有一致努力通过备案教育和促进处方,但这些障碍的一些障碍仍然存在。虽然我们的研究受小型选择性样本大小的限制,但结果表明有必要改进课程。科学意义我们的研究解决了一个未宣传的备案研究领域,可能会通知未来的计划开发。 (AM addict 2019; 00:00-00)

著录项

  • 来源
  • 作者单位

    Department of PharmacyUniversity of California San Diego HealthSan Diego California;

    Department of Pharmacy Practice and AdministrationWestern University of Health Sciences College of;

    Department of PharmacyUniversity of California San Diego HealthSan Diego California;

    Department of PsychiatryUniversity of California San Diego HealthSan Diego California;

    Department of PsychiatryUniversity of California San Diego HealthSan Diego California;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 中毒及化学性损害 ;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号